| Rimonabant | hsa00030 | Pentose phosphate pathway | 3.06E-04 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | |
| Rimonabant | hsa00220 | Arginine biosynthesis | 2.86E-02 | 2 | P15104, P05089 | GLUL, ARG1 | More | |
| Rimonabant | hsa00270 | Cysteine and methionine metabolism | 1.92E-02 | 2 | Q96RQ9, P40926 | IL4I1, MDH2 | More | |
| Rimonabant | hsa00500 | Starch and sucrose metabolism | 1.47E-02 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | |
| Rimonabant | hsa00512 | Mucin type O-glycan biosynthesis | 4.62E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | |
| Rimonabant | hsa00514 | Other types of O-glycan biosynthesis | 4.62E-02 | 2 | O15294, Q8N4A0 | OGT, GALNT4 | More | |
| Rimonabant | hsa00520 | Amino sugar and nucleotide sugar metabolism | 1.32E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | |
| Rimonabant | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 2.03E-02 | 1 | P35557 | GCK | More | |
| Rimonabant | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 6.96E-04 | 1 | Q9NY97 | B3GNT2 | More | |
| Rimonabant | hsa00562 | Inositol phosphate metabolism | 4.43E-02 | 3 | P27987, Q13572, P42338 | ITPKB, ITPK1, PIK3CB | More | |
| Rimonabant | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | |
| Rimonabant | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | |
| Rimonabant | hsa00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 3.78E-02 | 1 | Q9NY97 | B3GNT2 | More | |
| Rimonabant | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 6.21E-03 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | |
| Rimonabant | hsa00630 | Glyoxylate and dicarboxylate metabolism | 8.73E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | |
| Rimonabant | hsa00730 | Thiamine metabolism | 3.27E-04 | 3 | Q9Y6K8, P05186, P24666 | AK5, ALPL, ACP1 | More | |
| Rimonabant | hsa00740 | Riboflavin metabolism | 4.03E-02 | 1 | P24666 | ACP1 | More | |
| Rimonabant | hsa00760 | Nicotinate and nicotinamide metabolism | 3.52E-02 | 1 | P21589 | NT5E | More | |
| Rimonabant | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | |
| Rimonabant | hsa00830 | Retinol metabolism | 4.25E-02 | 1 | P00325 | ADH1B | More | |
| Rimonabant | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
| Rimonabant | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | |
| Rimonabant | hsa01100 | Metabolic pathways | 4.43E-02 | 23 | Q9NR34, P05089, P32320, P22748, P55809, P06280, Q16875, O43286, O43451, P05186, P24666, Q9HCC0, P33121, P57054, Q9UNP4, Q9BX95, P32321, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737 | MAN1C1, ARG1, CDA, CA4, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, ALPL, ACP1, MCCC2, ACSL1, PIGP, ST3GAL5, SGPP1, DCTD, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL | More | |
| Rimonabant | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | |
| Rimonabant | hsa01210 | 2-Oxocarboxylic acid metabolism | 1.91E-02 | 1 | P50213 | IDH3A | More | |
| Rimonabant | hsa01230 | Biosynthesis of amino acids | 2.60E-02 | 3 | P51854, P60891, P37837 | TKTL1, PRPS1, TALDO1 | More | |
| Rimonabant | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.82E-02 | 1 | P08069 | IGF1R | More | |
| Rimonabant | hsa01522 | Endocrine resistance | 1.69E-02 | 4 | P22694, P08069, P10415, Q13323 | PRKACB, IGF1R, BCL2, BIK | More | |
| Rimonabant | hsa02010 | ABC transporters | 4.48E-02 | 1 | Q8IZY2 | ABCA7 | More | |
| Rimonabant | hsa03015 | mRNA surveillance pathway | 1.83E-02 | 3 | Q13362, Q14738, Q9UBU9 | PPP2R5C, PPP2R5D, NXF1 | More | |
| Rimonabant | hsa03040 | Spliceosome | 3.37E-02 | 6 | O60508, P08579, P26368, Q01130, Q9Y2W2, O43447 | CDC40, SNRPB2, U2AF2, SFRS2, WBP11, PPIH | More | |
| Rimonabant | hsa03050 | Proteasome | 4.83E-02 | 1 | P55036 | PSMD4 | More | |
| Rimonabant | hsa04010 | MAPK signaling pathway | 1.61E-02 | 6 | Q15283, P21860, P08069, Q12933, P01584, O14944 | RASA2, ERBB3, IGF1R, TRAF2, IL1B, EREG | More | |
| Rimonabant | hsa04014 | Ras signaling pathway | 3.65E-02 | 1 | P08069 | IGF1R | More | |
| Rimonabant | hsa04015 | Rap1 signaling pathway | 2.99E-02 | 1 | P08069 | IGF1R | More | |
| Rimonabant | hsa04020 | Calcium signaling pathway | 3.61E-02 | 4 | Q96DU7, Q08828, Q13557, P21860 | ITPKC, ADCY1, CAMK2D, ERBB3 | More | |
| Rimonabant | hsa04060 | Cytokine-cytokine receptor interaction | 4.24E-03 | 11 | P27930, P14778, P26842, Q13651, P78552, P25024, O75509, P09341, P18510, P09603, P01730 | IL1R2, IL1R1, CD27, IL10RA, IL13RA1, CXCR1, TNFRSF21, CXCL1, IL1RN, CSF1, CD4 | More | |
| Rimonabant | hsa04064 | NF-kappa B signaling pathway | 2.99E-02 | 7 | O00463, P14778, Q13077, Q16548, Q8WV28, P24522, P09341 | TRAF5, IL1R1, TRAF1, BCL2A1, BLNK, GADD45A, CXCL1 | More | |
| Rimonabant | hsa04066 | HIF-1 signaling pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | |
| Rimonabant | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | |
| Rimonabant | hsa04071 | Sphingolipid signaling pathway | 1.19E-02 | 4 | P21453, Q9H228, P01375, Q13362 | S1PR1, EDG8, TNF, PPP2R5C | More | |
| Rimonabant | hsa04072 | Phospholipase D signaling pathway | 9.70E-03 | 2 | Q92529, Q14344 | SHC3, GNA13 | More | |
| Rimonabant | hsa04080 | Neuroactive ligand-receptor interaction | 2.95E-04 | 8 | P08311, P28472, Q15722, P21453, Q9H228, O00398, P21730, P07550 | CTSG, GABRB3, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, ADRB2 | More | |
| Rimonabant | hsa04114 | Oocyte meiosis | 1.11E-05 | 9 | Q9Y6D9, P51812, Q02750, P0DP23, P16298, Q17RY0, Q13362, Q14738, P08069 | MAD1L1, RPS6KA3, MAP2K1, CALM1, PPP3CB, CPEB4, PPP2R5C, PPP2R5D, IGF1R | More | |
| Rimonabant | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | |
| Rimonabant | hsa04140 | Autophagy - animal | 2.81E-02 | 4 | P08069, P22694, Q14643, P10415 | IGF1R, PRKACB, ITPR1, BCL2 | More | |
| Rimonabant | hsa04144 | Endocytosis | 4.10E-02 | 3 | O75351, P62491, Q14161 | VPS4B, RAB11A, GIT2 | More | |
| Rimonabant | hsa04150 | mTOR signaling pathway | 7.74E-03 | 4 | P08069, Q02750, Q9NQL2, P51812 | IGF1R, MAP2K1, RRAGD, RPS6KA3 | More | |
| Rimonabant | hsa04152 | AMPK signaling pathway | 2.37E-03 | 4 | P08069, Q96RR4, Q13362, Q14738 | IGF1R, CAMKK2, PPP2R5C, PPP2R5D | More | |
| Rimonabant | hsa04211 | Longevity regulating pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | |
| Rimonabant | hsa04213 | Longevity regulating pathway - multiple species | 1.66E-02 | 1 | P08069 | IGF1R | More | |
| Rimonabant | hsa04215 | Apoptosis - multiple species | 1.56E-02 | 2 | Q13489, P10415 | BIRC3, BCL2 | More | |
| Rimonabant | hsa04217 | Necroptosis | 2.34E-02 | 4 | P01375, P48023, Q14765, Q99878 | TNF, FASLG, STAT4, H2AC14 | More | |
| Rimonabant | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.75E-03 | 6 | P07550, P22694, P18848, Q13362, Q14738, P0DP23 | ADRB2, PRKACB, ATF4, PPP2R5C, PPP2R5D, CALM1 | More | |
| Rimonabant | hsa04340 | Hedgehog signaling pathway | 9.74E-03 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | |
| Rimonabant | hsa04370 | VEGF signaling pathway | 2.58E-05 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | |
| Rimonabant | hsa04390 | Hippo signaling pathway | 2.17E-03 | 5 | P63261, P84022, Q13485, O15105, Q13489 | ACTG1, SMAD3, SMAD4, SMAD7, BIRC3 | More | |
| Rimonabant | hsa04510 | Focal adhesion | 3.48E-02 | 1 | P08069 | IGF1R | More | |
| Rimonabant | hsa04520 | Adherens junction | 8.29E-03 | 1 | P08069 | IGF1R | More | |
| Rimonabant | hsa04530 | Tight junction | 3.60E-03 | 5 | P63261, P16989, P56750, Q92974, Q14247 | ACTG1, CSDA, CLDN17, ARHGEF2, CTTN | More | |
| Rimonabant | hsa04540 | Gap junction | 2.86E-02 | 3 | P22694, P68371, Q14643 | PRKACB, TUBB2C, ITPR1 | More | |
| Rimonabant | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.99E-02 | 1 | P08069 | IGF1R | More | |
| Rimonabant | hsa04610 | Complement and coagulation cascades | 1.91E-03 | 1 | P0C0L4 | C4A | More | |
| Rimonabant | hsa04612 | Antigen processing and presentation | 1.07E-03 | 6 | Q14953, P26715, P26717, Q13241, P01732, P01375 | KIR2DS5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | |
| Rimonabant | hsa04613 | Neutrophil extracellular trap formation | 1.73E-02 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
| Rimonabant | hsa04640 | Hematopoietic cell lineage | 7.16E-03 | 7 | P13612, P14778, P27930, P07766, P01730, P09564, P09603 | ITGA4, IL1R1, IL1R2, CD3E, CD4, CD7, CSF1 | More | |
| Rimonabant | hsa04650 | Natural killer cell mediated cytotoxicity | 6.48E-06 | 10 | P16298, P50591, P01375, P20963, Q02750, Q13241, P26718, P26717, Q14953, P26715 | PPP3CB, TNFSF10, TNF, CD247, MAP2K1, KLRD1, KLRK1, KLRC2, KIR2DS5, KLRC1 | More | |
| Rimonabant | hsa04657 | IL-17 signaling pathway | 3.33E-03 | 8 | O00463, Q16539, P49841, P09341, P19875, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, CXCL2, MMP9, LCN2, TNF | More | |
| Rimonabant | hsa04658 | Th1 and Th2 cell differentiation | 4.54E-03 | 6 | P07766, P20963, P01730, P06239, Q9UL17, Q13761 | CD3E, CD247, CD4, LCK, TBX21, RUNX3 | More | |
| Rimonabant | hsa04659 | Th17 cell differentiation | 1.48E-03 | 9 | P25963, P01730, P06239, P14778, Q9UL17, P84022, Q13485, P07766, P20963 | NFKBIA, CD4, LCK, IL1R1, TBX21, SMAD3, SMAD4, CD3E, CD247 | More | |
| Rimonabant | hsa04662 | B cell receptor signaling pathway | 4.54E-03 | 5 | P49841, P42338, P60033, P07948, Q8N149 | GSK3B, PIK3CB, CD81, LYN, LILRA2 | More | |
| Rimonabant | hsa04664 | Fc epsilon RI signaling pathway | 4.43E-02 | 3 | P42338, P07948, P09917 | PIK3CB, LYN, ALOX5 | More | |
| Rimonabant | hsa04668 | TNF signaling pathway | 1.39E-03 | 8 | P01375, Q12933, Q99941, P18848, P19875, P01584, P14780, O95429 | TNF, TRAF2, CREBL1, ATF4, CXCL2, IL1B, MMP9, BAG4 | More | |
| Rimonabant | hsa04713 | Circadian entrainment | 4.25E-02 | 3 | Q13557, Q02153, Q08828 | CAMK2D, GUCY1B3, ADCY1 | More | |
| Rimonabant | hsa04720 | Long-term potentiation | 1.32E-03 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | |
| Rimonabant | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | |
| Rimonabant | hsa04724 | Glutamatergic synapse | 1.39E-05 | 6 | P48058, O15399, P43003, P63218, P50151, P15104 | GRIA4, GRIN2D, SLC1A3, GNG5, GNG10, GLUL | More | |
| Rimonabant | hsa04725 | Cholinergic synapse | 3.74E-02 | 3 | P22694, Q14643, P10415 | PRKACB, ITPR1, BCL2 | More | |
| Rimonabant | hsa04727 | GABAergic synapse | 2.78E-03 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | |
| Rimonabant | hsa04728 | Dopaminergic synapse | 2.66E-02 | 3 | Q13362, Q14738, P0DP23 | PPP2R5C, PPP2R5D, CALM1 | More | |
| Rimonabant | hsa04730 | Long-term depression | 1.86E-03 | 3 | Q14344, P08069, P07948 | GNA13, IGF1R, LYN | More | |
| Rimonabant | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.25E-02 | 3 | P01584, Q08828, Q13557 | IL1B, ADCY1, CAMK2D | More | |
| Rimonabant | hsa04911 | Insulin secretion | 2.23E-02 | 3 | Q08828, Q99941, Q13557 | ADCY1, CREBL1, CAMK2D | More | |
| Rimonabant | hsa04913 | Ovarian steroidogenesis | 6.27E-04 | 3 | P42330, P22694, P08069 | AKR1C3, PRKACB, IGF1R | More | |
| Rimonabant | hsa04914 | Progesterone-mediated oocyte maturation | 2.59E-04 | 5 | P08069, Q17RY0, Q9Y6D9, P51812, Q02750 | IGF1R, CPEB4, MAD1L1, RPS6KA3, MAP2K1 | More | |
| Rimonabant | hsa04921 | Oxytocin signaling pathway | 3.13E-02 | 3 | P0DP23, Q96RR4, Q13469 | CALM1, CAMKK2, NFATC2 | More | |
| Rimonabant | hsa04924 | Renin secretion | 2.90E-04 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | |
| Rimonabant | hsa04926 | Relaxin signaling pathway | 2.41E-02 | 4 | P18848, P22694, P14780, P30679 | ATF4, PRKACB, MMP9, GNA15 | More | |
| Rimonabant | hsa04927 | Cortisol synthesis and secretion | 1.27E-03 | 3 | Q14643, P18848, P22694 | ITPR1, ATF4, PRKACB | More | |
| Rimonabant | hsa04928 | Parathyroid hormone synthesis, secretion and action | 1.02E-02 | 4 | Q14643, P22694, P23771, P10415 | ITPR1, PRKACB, GATA3, BCL2 | More | |
| Rimonabant | hsa04932 | Non-alcoholic fatty liver disease | 2.57E-03 | 7 | P01375, P49841, P48023, Q12933, P01584, P12074, O15239 | TNF, GSK3B, FASLG, TRAF2, IL1B, COX6A1, NDUFA1 | More | |
| Rimonabant | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.25E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | |
| Rimonabant | hsa04934 | Cushing syndrome | 8.07E-04 | 7 | Q14643, Q99941, Q08828, P22694, O15169, Q13557, P04628 | ITPR1, CREBL1, ADCY1, PRKACB, AXIN1, CAMK2D, WNT1 | More | |
| Rimonabant | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
| Rimonabant | hsa04950 | Maturity onset diabetes of the young | 2.03E-02 | 1 | P35557 | GCK | More | |
| Rimonabant | hsa04960 | Aldosterone-regulated sodium reabsorption | 4.38E-02 | 1 | P48048 | KCNJ1 | More | |
| Rimonabant | hsa04962 | Vasopressin-regulated water reabsorption | 1.80E-02 | 2 | P62491, P46459 | RAB11A, NSF | More | |
| Rimonabant | hsa04964 | Proximal tubule bicarbonate reclamation | 4.48E-02 | 1 | P00918 | CA2 | More | |
| Rimonabant | hsa04966 | Collecting duct acid secretion | 4.48E-02 | 1 | P00918 | CA2 | More | |
| Rimonabant | hsa04970 | Salivary secretion | 9.44E-04 | 4 | P07550, P22694, Q14643, P49913 | ADRB2, PRKACB, ITPR1, CAMP | More | |
| Rimonabant | hsa04975 | Fat digestion and absorption | 3.43E-02 | 1 | O14494 | PLPP1 | More | |
| Rimonabant | hsa04979 | Cholesterol metabolism | 1.61E-02 | 2 | P38571, P61916 | LIPA, NPC2 | More | |
| Rimonabant | hsa05010 | Alzheimer disease | 1.23E-02 | 8 | Q92542, O15239, P05496, P12074, P01584, Q12933, O15169, P43686 | NCSTN, NDUFA1, ATP5G1, COX6A1, IL1B, TRAF2, AXIN1, PSMC4 | More | |
| Rimonabant | hsa05012 | Parkinson disease | 3.53E-02 | 6 | P62987, O15239, P12074, P05496, P43686, Q13557 | UBA52, NDUFA1, COX6A1, ATP5G1, PSMC4, CAMK2D | More | |
| Rimonabant | hsa05014 | Amyotrophic lateral sclerosis | 2.99E-02 | 7 | O15239, P12074, P05496, Q12933, P43686, P37198, P35658 | NDUFA1, COX6A1, ATP5G1, TRAF2, PSMC4, NUP62, NUP214 | More | |
| Rimonabant | hsa05017 | Spinocerebellar ataxia | 1.43E-02 | 4 | Q92915, O15399, P42338, P21796 | FGF14, GRIN2D, PIK3CB, VDAC1 | More | |
| Rimonabant | hsa05020 | Prion disease | 2.99E-02 | 7 | P01584, P46531, O15239, P05496, P12074, P43686, Q99941 | IL1B, NOTCH1, NDUFA1, ATP5G1, COX6A1, PSMC4, CREBL1 | More | |
| Rimonabant | hsa05022 | Pathways of neurodegeneration - multiple diseases | 9.10E-03 | 9 | O15239, P12074, P05496, Q12933, O15169, P01584, Q13557, P62987, P43686 | NDUFA1, COX6A1, ATP5G1, TRAF2, AXIN1, IL1B, CAMK2D, UBA52, PSMC4 | More | |
| Rimonabant | hsa05031 | Amphetamine addiction | 4.32E-02 | 3 | P22694, P18848, Q13547 | PRKACB, ATF4, HDAC1 | More | |
| Rimonabant | hsa05034 | Alcoholism | 2.89E-03 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
| Rimonabant | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.45E-02 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | |
| Rimonabant | hsa05132 | Salmonella infection | 2.04E-02 | 4 | P25963, Q13489, P10415, Q9BQS8 | NFKBIA, BIRC3, BCL2, FYCO1 | More | |
| Rimonabant | hsa05133 | Pertussis | 3.51E-02 | 1 | P0C0L4 | C4A | More | |
| Rimonabant | hsa05135 | Yersinia infection | 4.71E-02 | 4 | Q05397, P51812, Q02750, Q96JJ3 | PTK2, RPS6KA3, MAP2K1, ELMO2 | More | |
| Rimonabant | hsa05140 | Leishmaniasis | 2.69E-02 | 5 | O75015, P13765, O60603, P49006, Q16539 | FCGR3B, HLA-DOB, TLR2, MARCKSL1, MAPK14 | More | |
| Rimonabant | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | |
| Rimonabant | hsa05144 | Malaria | 1.91E-02 | 3 | P01375, P35443, P26718 | TNF, THBS4, KLRK1 | More | |
| Rimonabant | hsa05145 | Toxoplasmosis | 2.78E-02 | 3 | P25963, P10415, Q13489 | NFKBIA, BCL2, BIRC3 | More | |
| Rimonabant | hsa05146 | Amoebiasis | 5.57E-05 | 11 | Q13751, P09341, P19875, P14778, P27930, P01375, O60603, P05089, P30679, P22694, P12814 | LAMB3, CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, ARG1, GNA15, PRKACB, ACTN1 | More | |
| Rimonabant | hsa05150 | Staphylococcus aureus infection | 1.31E-02 | 2 | P0C0L4, P13646 | C4A, KRT13 | More | |
| Rimonabant | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | |
| Rimonabant | hsa05161 | Hepatitis B | 8.49E-03 | 4 | P25963, Q13485, P10415, P84022 | NFKBIA, SMAD4, BCL2, SMAD3 | More | |
| Rimonabant | hsa05163 | Human cytomegalovirus infection | 1.15E-03 | 12 | P42338, P63218, P50151, Q14643, Q14344, P49841, P14778, P25025, Q16539, P04637, O00463, P30101 | PIK3CB, GNG5, GNG10, ITPR1, GNA13, GSK3B, IL1R1, CXCR2, MAPK14, TP53, TRAF5, PDIA3 | More | |
| Rimonabant | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 2.39E-03 | 7 | P23458, P62879, Q13469, P16298, Q02750, P0DP23, P0CG47 | JAK1, GNB2, NFATC2, PPP3CB, MAP2K1, CALM1, UBB | More | |
| Rimonabant | hsa05170 | Human immunodeficiency virus 1 infection | 6.02E-03 | 5 | Q02750, P62879, P16298, Q05397, P20333 | MAP2K1, GNB2, PPP3CB, PTK2, TNFRSF1B | More | |
| Rimonabant | hsa05202 | Transcriptional misregulation in cancer | 2.82E-02 | 1 | P08069 | IGF1R | More | |
| Rimonabant | hsa05203 | Viral carcinogenesis | 4.85E-02 | 3 | Q15283, P62807, O60814 | RASA2, HIST1H2BC, H2BC12 | More | |
| Rimonabant | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
| Rimonabant | hsa05205 | Proteoglycans in cancer | 1.09E-02 | 6 | P14780, P01375, P08069, P23588, Q13635, P22694 | MMP9, TNF, IGF1R, EIF4B, PTCH1, PRKACB | More | |
| Rimonabant | hsa05210 | Colorectal cancer | 1.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | |
| Rimonabant | hsa05212 | Pancreatic cancer | 3.09E-03 | 4 | Q15311, P23458, P84022, Q13485 | RALBP1, JAK1, SMAD3, SMAD4 | More | |
| Rimonabant | hsa05213 | Endometrial cancer | 3.79E-02 | 2 | O15169, Q02750 | AXIN1, MAP2K1 | More | |
| Rimonabant | hsa05214 | Glioma | 9.95E-03 | 1 | P08069 | IGF1R | More | |
| Rimonabant | hsa05215 | Prostate cancer | 1.33E-02 | 1 | P08069 | IGF1R | More | |
| Rimonabant | hsa05218 | Melanoma | 6.63E-03 | 1 | P08069 | IGF1R | More | |
| Rimonabant | hsa05219 | Bladder cancer | 4.07E-02 | 2 | P14780, P04637 | MMP9, TP53 | More | |
| Rimonabant | hsa05220 | Chronic myeloid leukemia | 1.25E-02 | 3 | Q13485, P25963, P84022 | SMAD4, NFKBIA, SMAD3 | More | |
| Rimonabant | hsa05222 | Small cell lung cancer | 1.50E-02 | 3 | Q13489, P10415, P25963 | BIRC3, BCL2, NFKBIA | More | |
| Rimonabant | hsa05224 | Breast cancer | 1.24E-02 | 5 | P08069, P49841, Q92837, P04637, P24522 | IGF1R, GSK3B, FRAT1, TP53, GADD45A | More | |
| Rimonabant | hsa05225 | Hepatocellular carcinoma | 6.30E-04 | 3 | Q92529, P08069, P51531 | SHC3, IGF1R, SMARCA2 | More | |
| Rimonabant | hsa05226 | Gastric cancer | 4.33E-03 | 5 | Q02750, O15169, P84022, Q13485, P10415 | MAP2K1, AXIN1, SMAD3, SMAD4, BCL2 | More | |
| Rimonabant | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.55E-02 | 5 | O95267, P09693, O60603, Q16539, P01730 | RASGRP1, CD3G, TLR2, MAPK14, CD4 | More | |
| Rimonabant | hsa05321 | Inflammatory bowel disease | 1.91E-02 | 3 | P01375, Q14765, Q9UL17 | TNF, STAT4, TBX21 | More | |
| Rimonabant | hsa05322 | Systemic lupus erythematosus | 1.31E-04 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
| Rimonabant | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
| Rimonabant | hsa05332 | Graft-versus-host disease | 7.27E-04 | 4 | P48023, P01375, P26715, Q13241 | FASLG, TNF, KLRC1, KLRD1 | More | |
| Rimonabant | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.48E-02 | 1 | P54284 | CACNB3 | More | |
| Rimonabant | hsa05414 | Dilated cardiomyopathy | 4.55E-02 | 2 | P54284, P26678 | CACNB3, PLN | More | |
| Rimonabant | hsa05418 | Fluid shear stress and atherosclerosis | 2.62E-02 | 6 | Q16539, P10599, P14780, P04637, P14778, P27930 | MAPK14, TXN, MMP9, TP53, IL1R1, IL1R2 | More | |
